Medical Technology Corporation (MTC)

Classification: Confidential - ‫رسي‬
Medical Technology Corporation
(MTC)

Executive Summary
Short-Term Improvement Plans (Within 1 Year)
1. Enhance Forecasting Methods: Implement advanced forecasting
techniques to optimize inventory management, resulting in
significant cost reductions.
2. Reevaluate Sales Representatives' Roles: Revise job descriptions
for sales representatives to align their responsibilities with evolving
market dynamics and customer needs.
3. Eliminate Unrealized Revenue (Trunk Costs): Identify and eliminate
hidden costs that have been inhibiting revenue growth, thus
unlocking untapped income potential.
4. Streamline Inventory Management: Implement strategies to
improve inventory efficiency, reducing carrying costs and ensuring
product availability.
5. Cultivate Customer Relationships: Strengthen customer
relationships through enhanced communication and tailored
services, fostering loyalty and increased sales.
These short-term improvement initiatives aim to enhance operational
efficiency, boost revenue, and improve customer satisfaction within the
next year.
Mid-Term Improvement Plans (Within 3-5 Years)
1.Insourcing Sterilization:
1. Faster Processing and Delivery: By bringing sterilization in-house, we
can expedite product processing and delivery.
2. Cost Reduction: Insourcing reduces outsourcing costs and overhead,
contributing to cost savings.
3. Quality Management: Ensuring greater control over sterilization
processes allows for improved quality management.
2.Implement Lean/Just-in-Time (JIT) Production:
1. Increased Efficiency: JIT production enhances production and
distribution efficiency by reducing waste and optimizing resource
utilization.
2. Expense Reduction: Minimizing unnecessary expenses and inventory
holding costs through lean practices.
3.Direct Sales to GPOs (Group Purchasing Organizations):
1. Enhanced Customer Relationships: Cutting out intermediaries and
selling directly to GPOs strengthens our relationships with key
customers.
2. Retail Price Control: Selling directly allows us to set retail prices,
potentially increasing profitability.
4.Partnership with 3PLs (Third-Party Logistics) and RFID
Implementation:
1. Streamlined Distribution: Collaborating with 3PLs and implementing
RFID technology streamlines distribution processes, reducing transit
times.
2. Enhanced Product Visibility: RFID enhances product visibility,
providing real-time tracking and inventory management capabilities.
These mid-term strategies are designed to optimize operations, reduce
costs, and further enhance customer relations, positioning us for long-
term success in the market.

Executive Summary
Long-Term Improvement Plans (5-7 Years and Beyond)
Emphasis on Research and Development (R&D):
1. Innovative Product Creation: Investing in R&D allows us to develop cutting-edge products that
address evolving customer needs and market trends.
2. Added Customer Value: These innovations bring more value to our customers, enhancing their
experience and loyalty.
3. Long-Term Relationship Enhancement: Continual R&D efforts demonstrate our commitment
to long-term customer satisfaction and strengthen our relationships with them.
4. Diversified Revenue Streams: New and innovative products open up diversified revenue
streams, reducing dependency on existing offerings.
By prioritizing research and development over the long term, we position ourselves as a
forward-thinking industry leader, fostering sustainable growth and success.

Decisive Metrics and Key performance indicators
Key Metrics Considered for Decision-
Making
In the process of arriving at solutions, the following decisive metrics
were thoroughly analyzed and addressed:
1.Increase in Net Earnings: Focusing on strategies to boost net earnings
by optimizing revenue and cost management.
2.Increase in Operating Margin: Exploring ways to enhance the operating
margin, which signifies efficiency and profitability.
3.Control on SG&A (Selling, General, and Administrative
Expenses) and COGS (Cost of Goods Sold): Implementing measures to
manage and reduce SG&A and COGS, directly impacting profitability.
4.Inventory Turnover: Evaluating the efficiency of inventory management
by monitoring how quickly inventory is sold or used up.
5.Days Inventory on Hold (Finished Goods to Inventory): Assessing
the time it takes for finished goods to be converted into revenue, aiming for
shorter holding periods.
6.On-Time Delivery: Ensuring products are delivered to customers as per
commitments to maintain customer satisfaction.
7.Products in Compliance: Guaranteeing that products meet regulatory
and quality standards to avoid compliance-related issues.
These decisive metrics guided the decision-making process, ensuring
that strategies and solutions align with the company's financial goals,
operational efficiency, and customer satisfaction objectives.
Key Metrics Considered for Decision-
Making
Key Performance Indicators (KPIs) for Evaluating Solutions:
1.Sustainability:
a) Long-Term Viability: Assess whether the implemented solutions can be
sustained over the long term while continuing to deliver benefits.
b) Environmental Impact: Monitor the environmental sustainability of the
solutions, considering factors like reduced carbon footprint and resource
conservation.
2.Feasibility:
a) Seamless Rollout: Evaluate the ease and practicality of implementing the
solutions without disruptions or complications.
b) Resource Requirements: Determine if the necessary resources,
including manpower and technology, are readily available for a smooth
implementation.
3.Strategic Objectives:
a) Alignment with Company Goals: Measure how well the solutions align
with the overarching strategic objectives of the organization.
b) Strategic Agility: Assess if the solutions provide flexibility to adapt to
changing business needs and goals.
4.Cost Savings:
a) Cost Reduction: Track the extent to which the solutions contribute to
achieving targeted cost savings.
b) Return on Investment (ROI): Calculate the ROI and ensure it meets or
exceeds expectations.
Monitoring these KPIs will provide valuable insights into the effectiveness and
sustainability of the implemented solutions, helping the organization make
informed decisions and adjustments as needed to achieve its goals.

MTC's Market Segmentation
Market segmentation is a crucial strategy for MTC, headquartered in Collegeville, PA, which specializes in the manufacturing and supply of essential
medical devices, including surgical kits, to various markets. Here's an overview of MTC's market segmentation:
1.Healthcare Facilities:
a) Hospitals: MTC likely serves large, medium, and small hospitals, addressing their diverse surgical kit needs.
b) Clinics and Outpatient Centers: Providing tailored solutions for healthcare facilities outside traditional hospitals.
2.Geographic Segmentation:
a) Domestic Market (USA): MTC may focus on supplying medical devices to healthcare institutions within the United States.
b) International Market: Exploring opportunities to export surgical kits to hospitals and healthcare facilities globally.
3.Specialty Markets:
a) Specialized Medical Facilities: Targeting specialized medical facilities such as research institutes, dental clinics, and eye surgery centers.
b) Veterinary Care: Providing medical devices for veterinary practices and animal hospitals.
4.Customer Size:
a) Large Enterprises: Serving major hospitals and medical institutions with bulk orders and tailored services.
b) Mid-sized Facilities: Addressing the needs of medium-sized healthcare centers.
c) Small Clinics: Offering cost-effective solutions for smaller healthcare providers.
5.Government and Public Health:
a) Government Contracts: Pursuing government contracts to supply surgical kits to public healthcare institutions and military facilities.
b) Public Health Initiatives: Participating in public health programs, disaster response, and humanitarian missions.
6.Customization and Specialization:
a) Customized Solutions: Offering tailored surgical kit solutions for specific medical procedures and disciplines.
b) Innovation for Niche Markets: Developing specialized devices for emerging healthcare segments.
MTC's market segmentation strategy allows them to diversify their customer base and tailor their product offerings to meet the unique needs of various
healthcare sectors and regions. This approach helps them remain competitive and adaptable in the dynamic medical device industry.

Key Financial Insights
1. Revenue
•Experienced robust growth, surging by an impressive 11% from 2010 to 2012.
•Subsequently, growth tapered down to a still respectable 4%.
2. Cost of Goods Sold
•Demonstrated steady growth with an average annual rate of 8%.
3. Selling, General, and Administrative Expenses (SG&A)
•In 2010, SG&A accounted for 37% of revenue, but by 2014, it constituted over 45%.
•The average annual growth rate for SG&A expenses during this period was a substantial 13%.
4. Research, Development, and Engineering Expenses (R&D)
•In 2014, R&D expenses were just 6% of total revenue, indicating relatively low investment in this area.
5. Net Earnings
•Witnessed a healthy 10% growth rate from 2010 to 2012.
•However, post-2012, net earnings contracted, experiencing a significant decline of 14%.
These enhanced financial insights offer a clear and concise overview of the company's performance
over time, highlighting key metrics such as revenue, expenses, and net earnings. The use of bullet
points and concise language makes the information easy to digest for readers.

Navigating the New Medical Device Excise Tax
• In light of recent developments, the federal government has introduced the
Affordable Care Act (ACA), which brings with it a notable change in the form of
a Medical Device Excise Tax, levied at 2.3% of our revenue. This tax
imposition translates directly into a 10% reduction in our profits.
• To effectively address this challenge and maintain our financial health, we are
actively strategizing to optimize our supply chain. By doing so, we aim to
generate cost savings that can offset the impact of this new tax, ensuring our
continued success in a changing regulatory landscape.
• This revised text provides a more detailed and impactful explanation of the
situation, emphasizing the need for proactive measures to counteract the tax's
effect and maintain profitability.

Improvement Plans
Short-term: Revamp Sales Representatives' Job Descriptions
In our pursuit of operational excellence, we've recognized the need to revamp the job descriptions of our sales representatives.
This initiative stems from a comparative analysis with industry standards. According to Medreps.com, the average total
compensation for medical device sales representatives stands at $180,146. Remarkably, our sales representatives currently
receive an average pay of $300,000, which represents a significant 67% higher compensation.
Benefits of this Initiative:
•Elimination of 'Trunk Stocks': By redefining the role of our sales representatives, we aim to eliminate the need for "trunk
stocks," reducing unnecessary inventory burdens.
•Enhanced Inventory Management: This revamp will lead to better inventory management practices, optimizing our resources
and reducing carrying costs.
•Reduction in SG&A Costs: We anticipate a reduction in Selling, General, and Administrative (SG&A) costs, contributing to
improved profitability.
•Strengthened Supplier-Customer Relationships: Our revised approach will allow our sales representatives to foster more
focused, productive relationships with our suppliers and customers, enhancing overall business interactions.
Risks and Mitigation Strategy:
One potential risk associated with this transition is employee resistance. However, we are committed to ensuring a collaborative
and careful process throughout the transition. Open communication channels, feedback mechanisms, and employee involvement
will be integral components of our strategy to overcome resistance and facilitate a smooth implementation.
This refined plan outlines the rationale, benefits, and risks associated with the short-term improvement initiative, offering a more
comprehensive and persuasive overview of the proposed changes and their potential impact.

Improvement Plans
Mid-term: Insource Sterilization of Our Products
In our continuous pursuit of operational excellence and cost-efficiency, we are embarking on a significant strategic shift—insourcing the sterilization of
our products. This substantial change in our operations is aimed at optimizing various facets of our business.
•Simpler Operations: By bringing sterilization in-house, we streamline our operations and reduce complexity.
•Considerable Reduction in Transportation Costs: Insourcing sterilization will substantially cut transportation expenses associated with outsourcing
this critical function.
•Fewer Handling and Touch Points: Our products will undergo fewer handling and touch points, reducing the risk of contamination and potential
damage.
•Increased Control Over Processing and Quality: We gain complete control over the sterilization process, ensuring the highest quality standards
are met consistently.
•Improved Lead Time by 4 Days: With sterilization performed in-house, our lead times will improve significantly, enhancing our responsiveness to
customer demand.
•More Responsive to Customer Demand: This change allows us to adapt swiftly to fluctuations in customer demand, enhancing customer
satisfaction.
•Not Currently Performed: While sterilization is not currently performed in-house, we are prepared to mitigate this risk through meticulous planning
and training. We will invest in the necessary resources to ensure a smooth transition.
•High Capital Investment: Insourcing sterilization does require a significant initial capital investment. However, this expenditure will be redeemed over
time through lower transportation costs, the improved quality of our products, and an expected increase in sales resulting from enhanced operational
efficiency.
This mid-term plan outlines a strategic shift that promises substantial operational improvements while addressing the associated risks through detailed
planning and a focus on long-term financial gains. It presents a compelling case for the insourcing of sterilization as a prudent business move.

Improvement Plans
Mid-term: Implement Lean/Just-in-Time (JIT) Production
In our quest for operational excellence, we are embarking on a significant strategic shift – the implementation of Lean/Just-in-Time
(JIT) production methods. This initiative is aimed at optimizing our manufacturing processes by producing precisely what we need,
when we need it.
•Eliminate Waste and Save Space: By producing only what is necessary, we effectively eliminate waste in the form of excess
inventory and underutilized space.
•Improved Inventory Management: JIT production allows us to maintain leaner inventories, reducing carrying costs and
improving overall inventory management.
•Avoid Excessive Units: We will no longer produce excessive units that may lead to obsolescence or overstock issues.
•Align Spending with Demand: JIT production ensures that our spending aligns closely with current demand, optimizing resource
allocation and reducing unnecessary expenses.
•Disruption due to External Risks: While JIT production can enhance efficiency, it may be vulnerable to external disruptions. To
mitigate this risk, we will implement an effective Kanban system. This system will provide real-time visibility into our production
needs and enable rapid adjustments in response to changing circumstances. Additionally, we will diversify our supplier base to
reduce dependence on a single source, enhancing supply chain resilience.
This mid-term plan highlights the advantages of Lean/JIT production methods while acknowledging potential risks and presenting
a clear strategy for risk mitigation. It underscores the importance of adaptability and efficient resource allocation in the face of
external uncertainties.

Improvement Plans
Mid-term: Direct Sales to Group Purchasing Organizations (GPOs)
In our ongoing pursuit of enhanced efficiency and customer engagement, we are exploring a transformative strategy –
bypassing distributors and establishing direct sales channels with Group Purchasing Organizations (GPOs). This initiative
promises to bring substantial benefits to our organization.
•Revenue Enhancement: By selling directly to GPOs instead of through intermediaries, we can capture a larger share of
the market's value, as we would be selling at retail prices rather than wholesale rates.
•More Direct Customer Relationship: Establishing direct connections with GPOs enables us to foster closer, more
collaborative relationships with our customers. This translates into a deeper understanding of their needs and preferences.
•Improved Customer Service: Our commitment to delivering top-notch customer service is reinforced by direct
interactions with GPOs. This enhances our ability to address customer concerns promptly and efficiently.
•Convincing GPOs: The primary risk associated with this strategy is the need to convince GPOs to include our products
directly in their catalogs, bypassing the distributor route. To mitigate this risk, we will employ a comprehensive approach.
This includes showcasing the advantages of our products, demonstrating cost savings, and highlighting the benefits of a
more direct partnership. We will also offer incentives or discounts to make our proposition more appealing to GPOs.
This mid-term plan emphasizes the potential revenue gains and improved customer relationships that can result from
direct sales to GPOs, while also recognizing the challenge of convincing GPOs to adopt this approach and providing a
clear strategy to address this challenge.

Improvement Plans
Mid-term: Partner with 3PLs and Implement RFID Technology
In our ongoing commitment to operational excellence, we are strategically moving forward with a partnership with Third-Party Logistics (3PL) providers
while implementing Radio-Frequency Identification (RFID) technology across our supply chain. This transformative initiative holds the promise of
significant benefits for our organization.
•More Efficient Logistics Network: Partnering with 3PLs allows us to tap into a network of experts, leading to a more streamlined and efficient
logistics operation.
•Better Control of Distribution: This partnership provides us with greater control over our distribution processes, ensuring products reach their
destinations reliably and on time.
•Greater Visibility with RFID: The implementation of RFID technology offers unparalleled visibility into our supply chain, enhancing tracking accuracy
and reducing the risk of errors.
•Automated and Real-Time Inventory Management: RFID technology enables automated and real-time inventory tracking, leading to reduced
manual labor and more accurate stock levels.
•Improves Production: With a more accurate understanding of inventory levels, we can optimize production processes, reducing waste and
inefficiency.
•No Stock-Outs: Improved inventory management ensures we avoid stock-outs, enhancing customer satisfaction and preventing revenue losses.
•Reduces Costs: Overall, this initiative reduces costs through improved efficiency, reduced manual labor, and minimized inventory issues.
•Capital Investment: While this initiative requires an initial capital investment, the returns on investment are expected to be substantial. We anticipate
recouping these investments through reduced operational costs, improved production efficiency, and enhanced customer satisfaction.
This mid-term plan underscores the advantages of partnering with 3PLs and implementing RFID technology in our supply chain, while also
acknowledging the upfront capital investment and providing a clear rationale for its potential long-term gains.

Improvement Plans
Mid-term: Partner with 3PLs and Implement RFID Technology
In our relentless pursuit of operational excellence, we are strategically advancing by forging partnerships with Third-Party Logistics (3PL) providers
while concurrently adopting cutting-edge Radio-Frequency Identification (RFID) technology throughout our supply chain. This transformational initiative
promises substantial benefits for our organization.
•More Efficient Logistics Network: Partnering with 3PLs allows us to harness the expertise of logistics specialists, leading to a more streamlined and
efficient network.
•Better Control of Distribution: This collaboration empowers us with enhanced control over our distribution processes, ensuring the consistent and
timely delivery of products.
•Greater Visibility through RFID: The implementation of RFID technology introduces unprecedented visibility into our supply chain, bolstering
tracking accuracy and reducing the likelihood of errors.
•Automated and Real-Time Inventory Management: RFID technology facilitates automated and real-time inventory tracking, resulting in reduced
manual labor and improved precision in managing stock levels.
•Production Enhancement: Armed with a more precise understanding of inventory levels, we can optimize production processes, thus curtailing
waste and inefficiencies.
•No Stock-Outs: The improved inventory management system ensures that we sidestep stock-outs, thus bolstering customer satisfaction and averting
revenue losses.
•Cost Reduction: Overall, this initiative is poised to reduce costs across the board through heightened operational efficiency, decreased manual labor
dependency, and the mitigation of inventory-related complications.
•Capital Investment Requirement: While this initiative demands an initial capital investment, the returns on this investment are anticipated to be
substantial. We are confident that this capital can be swiftly recouped through the operational efficiencies and cost reductions that this setup will
deliver.
This mid-term plan accentuates the advantages of 3PL partnerships and RFID technology adoption within our supply chain, while concurrently
acknowledging the need for upfront capital investment and providing a compelling rationale for its subsequent recovery through the realized
operational improvements and associated cost reductions.

Improvement Plans
Long-term: Strategic Emphasis on R&D for Innovation
In our long-term vision for sustained growth and competitiveness, we are directing our focus towards intensive Research and Development (R&D)
initiatives aimed at creating cutting-edge and innovative products. This strategic shift is designed to bring about transformative change in our
organization and foster long-lasting benefits.
•Better Customer Service: Through the introduction of innovative products, we aim to enhance our customer service by providing solutions that
address emerging needs and challenges.
•Stronger Supplier-Customer Relationship: R&D efforts can strengthen our supplier-customer relationships as we collaborate closely to bring
innovative products to market.
•Enhanced Revenue Streams: Innovative products have the potential to open up new revenue streams and expand market share, contributing to
sustained growth.
•Diversification of Operations and Offerings: R&D-driven innovation allows us to diversify our operations and offerings, reducing dependency on a
single product or market.
•Possible Tax Inversion: By investing in R&D and creating intellectual property, we may have the opportunity to explore tax inversion strategies,
optimizing our tax liabilities.
•Costly or Time-Consuming Development: There is a risk that the development of innovative products may be more expensive or time-consuming
than initially anticipated. To mitigate this, we will conduct thorough feasibility studies and project planning to ensure cost and time efficiency.
•Unsuccessful or Unworkable Products: The risk of developing products that do not meet market demands or are unworkable is inherent in
innovation. Our mitigation strategy involves ongoing market research, iterative development, and pilot testing to minimize such risks.
This long-term plan underscores the benefits of a strategic focus on R&D for innovation while acknowledging potential risks and presenting a clear
strategy for their mitigation. It demonstrates the importance of adaptability and forward-thinking in an ever-evolving business landscape.

Thank You

Medical Technology Corporation (MTC)

Recommended

Recommended

More Related Content

Similar to Medical Technology Corporation (MTC)

Similar to Medical Technology Corporation (MTC) (20)

Recently uploaded

Recently uploaded (20)

Medical Technology Corporation (MTC)